Paul joined Cipla Medpro as CEO in October 2013. A highly experienced pharmaceutical professional Paul was previously Vice President & Managing Director for Mylan in South Africa where he launched and grew the business to be among the top generic companies in the South African market.    

    Having done his MBA from University of Wales, Paul is highly regarded as someone who has a strategic understanding of how to build a business as well as launch and build brands. In China with Astra Zeneca from 2005 to 2008 Paul successfully built and launched innovative brands that became market leaders in the therapeutic areas of cardiovascular, gastrointestinal, respiratory and anaesthesia. This growth propelled the company to the number one position in China. Prior to 2005 Paul spent a number of years based in the UK, first as a Strategy & Portfolio Manager and then as Global Brand Manager, where he led and delivered a number of innovative and novel programmes to support the US, Asian & European market launches.